January 2026 Consumer Search Analysis Examines How Shoppers Evaluate Single-Ingredient vs Multi-Ingredient Berberine ...

Diabetes, a metabolic disease, is on the rise worldwide, and over 90% of cases are type 2 diabetes, where the body does not ...

Cardinal Health has introduced ContinuCare Pathway, a pharmacy-to-supplier referral pathway program designed to help retail ...

Researchers at the University of Oxford have discovered that the most common liver disease follows a strong day-night pattern ...

Researchers from Mass General Brigham and Albert Einstein College of Medicine identified molecular changes associated with type 2 diabetes risk, reflecting contributions from genetics, diet, and ...

Adults with type 2 diabetes and cancer who used a GLP-1 had a lower risk for death and hospitalization compared with adults ...

Remote monitoring is increasing as new reimbursement paths open up. But even the best programs are no guarantee of success.

A recent review examined how widely used treatments such as metformin, SGLT2 inhibitors, and GLP-1 receptor agonists may ...

A new study suggests that one of the most common diabetes treatments may speed type 2 diabetes progression by causing insulin ...

In a phase IIIb trial of adults with active psoriatic arthritis (PsA) and obesity or overweight, adding the GLP-1 drug ...

Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down.

Diabetes doesn’t just coexist with heart disease - it actively reshapes the heart’s machinery and the way it makes energy.